Seattle-based Frazier Healthcare Ventures has raised its largest venture fund, $600 million, which will allow the firm to make larger investments in later-stage deals for biotech, health care services and medical device companies. Frazier plans to invest in up to 27 life sciences firms and allocate about half of the new funding to early-stage deals.

Full Story:

Related Summaries